International Consensus Conference for Advanced Breast Cancer, Lisbon 2019
Standard
International Consensus Conference for Advanced Breast Cancer, Lisbon 2019 : ABC5 Consensus - Assessment by a German Group of Experts. / Thomssen, Christoph; Lüftner, Diana; Untch, Michael; Haidinger, Renate; Würstlein, Rachel; Harbeck, Nadia; Augustin, Doris; Briest, Susanne; Ettl, Johannes; Fasching, Peter A; Förster, Frank; Kurbacher, Christian M; Lück, Hans-Joachim; Marschner, Norbert; Müller, Lothar; Müller, Volkmar; Perlova-Griff, Lidia; Radke, Isabel; Ruckhäberle, Eugen; Scheffen, Iris; Schumacher-Wulf, Eva; Schwoerer, Moritz; Steinfeld-Birg, Dieter; Ziegler-Löhr, Katja.
In: BREAST CARE, Vol. 15, No. 1, 02.2020, p. 82-95.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - International Consensus Conference for Advanced Breast Cancer, Lisbon 2019
T2 - ABC5 Consensus - Assessment by a German Group of Experts
AU - Thomssen, Christoph
AU - Lüftner, Diana
AU - Untch, Michael
AU - Haidinger, Renate
AU - Würstlein, Rachel
AU - Harbeck, Nadia
AU - Augustin, Doris
AU - Briest, Susanne
AU - Ettl, Johannes
AU - Fasching, Peter A
AU - Förster, Frank
AU - Kurbacher, Christian M
AU - Lück, Hans-Joachim
AU - Marschner, Norbert
AU - Müller, Lothar
AU - Müller, Volkmar
AU - Perlova-Griff, Lidia
AU - Radke, Isabel
AU - Ruckhäberle, Eugen
AU - Scheffen, Iris
AU - Schumacher-Wulf, Eva
AU - Schwoerer, Moritz
AU - Steinfeld-Birg, Dieter
AU - Ziegler-Löhr, Katja
N1 - Copyright © 2020 by S. Karger AG, Basel.
PY - 2020/2
Y1 - 2020/2
N2 - The 5th International Consensus Conference for Advanced Breast Cancer (ABC5) took place on November 14-16, 2019, in Lisbon, Portugal. Its aim is to standardize the treatment of advanced breast cancer based on the available evidence and to ensure that all breast cancer patients worldwide receive adequate treatment and access to new therapies. This year, the conference focused on developments and study results in the treatment of patients with hormone receptor-positive/HER2-negative breast cancer as well as precision medicine. As in previous years, patient advocates from around the world were integrated into the ABC conference and had seats on the ABC consensus panel. In the present paper, a working group of German breast cancer experts comments on the results of the on-site ABC5 consensus votes by ABC panelists regarding their applicability for routine treatment in Germany. These comments take the recommendations of the Breast Committee of the Gynecological Oncology Working Group (Arbeitsgemeinschaft Gynäkologische Onkologie; AGO) into account. The report and assessment presented here pertain to the preliminary results of the ABC5 consensus. The final version of the statements will be published in Annals of Oncology and The Breast.
AB - The 5th International Consensus Conference for Advanced Breast Cancer (ABC5) took place on November 14-16, 2019, in Lisbon, Portugal. Its aim is to standardize the treatment of advanced breast cancer based on the available evidence and to ensure that all breast cancer patients worldwide receive adequate treatment and access to new therapies. This year, the conference focused on developments and study results in the treatment of patients with hormone receptor-positive/HER2-negative breast cancer as well as precision medicine. As in previous years, patient advocates from around the world were integrated into the ABC conference and had seats on the ABC consensus panel. In the present paper, a working group of German breast cancer experts comments on the results of the on-site ABC5 consensus votes by ABC panelists regarding their applicability for routine treatment in Germany. These comments take the recommendations of the Breast Committee of the Gynecological Oncology Working Group (Arbeitsgemeinschaft Gynäkologische Onkologie; AGO) into account. The report and assessment presented here pertain to the preliminary results of the ABC5 consensus. The final version of the statements will be published in Annals of Oncology and The Breast.
U2 - 10.1159/000505957
DO - 10.1159/000505957
M3 - SCORING: Journal article
C2 - 32231503
VL - 15
SP - 82
EP - 95
JO - BREAST CARE
JF - BREAST CARE
SN - 1661-3791
IS - 1
ER -